GW-0742 Powder

€ 39,95

GW-0742 powder is a thiazole-derived PPARβ/δ ligand presented by Raw Lab Chems with seller-specified ≥99% purity. The compound is intended exclusively for controlled in-vitro, chemical, and analytical research involving PPAR-related molecular pathways and compound characterization.

For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.

SKU: CERT-S-13122 Category:
Description

GW-0742 Powder

Product Overview

GW-0742 powder is a synthetic research compound studied primarily as a ligand of peroxisome proliferator-activated receptor beta/delta (PPARβ/δ). The supplied information identifies GW-0742 as a thiazole-derived PPARβ/δ agonist used experimentally to investigate receptor-mediated transcription and related molecular pathways.

Raw Lab Chems presents GW-0742 exclusively as a generic, brandless laboratory research material. The supplied specification states ≥99% purity, which is treated here as a seller-provided specification rather than independent analytical verification.

The scientific context surrounding GW-0742 includes experimental investigation of PPARδ-dependent gene expression, lipid and glucose metabolic pathways, mitochondrial biology, and comparative ligand chemistry. These topics describe areas of laboratory investigation rather than medical, metabolic, athletic, weight-management, or other personal-use benefits.

The source describes GW-0742 as highly selective for PPARδ compared with other PPAR subtypes. Such pharmacological characteristics remain research observations and are not presented as evidence of therapeutic suitability, safety, or physiological benefit.

Chemical Identity & Classification

The supplied chemical name for GW-0742 is [4-[[[2-[3-fluoro-4-(trifluoromethyl)phenyl]-4-methyl-5-thiazolyl]methyl]thio]-2-methylphenoxy]acetic acid.

The supplied molecular formula is C21H17F4NO3S2, and the stated molecular weight is approximately 471.5 g/mol.

GW-0742 is classified in the supplied information as a PPARβ/δ agonist and thiazole derivative. Its chemical description identifies structural features including fluorinated phenyl, trifluoromethyl, thiazole, thioether, phenoxy, and carboxylic-acid functionality.

The source additionally distinguishes GW-0742 structurally from GW-501516 by the presence of an additional fluorine substitution. Such distinctions are relevant when laboratories compare structurally related PPAR ligands or develop analytical methods intended to differentiate them.

Researchers can consult PubChem when reviewing public chemical-reference information, while confirming that any selected record corresponds precisely to the compound and chemical form being investigated.

No CAS number was supplied in the provided source, so none is invented or assigned here.

Chemical & Physical Characteristics

The supplied product information describes GW-0742 as a crystalline powder. No verified color, crystal form, particle-size distribution, melting point, density, hygroscopicity, or other detailed physical characteristics were supplied.

The source states that GW-0742 is soluble in DMSO, with a reported value of up to 25 mg/mL, and also describes solubility in ethanol. These values are retained as supplied reference information rather than represented as independently verified batch-specific measurements.

Solubility can vary with temperature, solvent composition, material form, concentration methodology, and other experimental conditions. Laboratories requiring quantitative solubility data should therefore use validated procedures and appropriate reference documentation.

The supplied storage information recommends room-temperature conditions of 15°C to 25°C in a dry, airtight container protected from light. No product-specific stability study or validated shelf-life dataset was supplied to establish long-term stability under those conditions.

Purity & Analytical Verification

The supplied specification for GW-0742 powder is ≥99% purity.

The source states that HPLC and NMR are used for verification and additionally references mass spectrometry for structural identity. However, no batch-specific chromatogram, NMR spectrum, mass spectrum, Certificate of Analysis, or independent laboratory report was supplied with the material provided.

Accordingly, the ≥99% value is presented as a seller-specified purity claim rather than independently verified analytical data.

HPLC, LC-MS, GC-MS, NMR, and related instrumental methods can be relevant to chemical characterization when appropriately validated for the research objective. Such methods may assist with investigation of identity, purity, structural characteristics, impurities, or differentiation from related PPAR ligands.

Reference to these analytical methods describes general laboratory context and supplied testing information. It does not independently establish that a specific Raw Lab Chems batch has undergone a particular analytical procedure.

Quality Control & Batch Integrity

Reliable research involving GW-0742 requires documentation connecting experimental observations to the precise material examined. Laboratory records can include chemical identity, molecular formula, supplier information, lot identifier, receipt date, storage history, analytical observations, and chain-of-custody information where appropriate.

The supplied information describes HPLC testing, mass-spectrometric and proton-NMR characterization, strict manufacturing protocols, batch consistency, and Certificate of Analysis availability.

No supporting batch records, spectra, chromatograms, manufacturing documentation, or Certificates of Analysis were supplied with the source information. These statements therefore should not be interpreted as independently established quality attributes.

Researchers requiring verified purity, structural identity, traceability, or batch consistency should rely on documentation applicable to the specific research material or conduct appropriate independent characterization.

No additional manufacturing, third-party certification, or lot-to-lot consistency guarantees are made here.

Safety, Handling & Laboratory Precautions

GW-0742 should be handled exclusively by appropriately trained personnel in a controlled laboratory environment. Suitable personal protective equipment, ventilation, containment, access restrictions, and waste-management procedures should be selected through institutional risk assessment and applicable safety documentation.

Its experimental interaction with PPAR pathways should be considered when laboratories establish controls for handling and research. Molecular or cellular activity does not establish safety or suitability for human or veterinary exposure.

Researchers should consult an applicable Safety Data Sheet for the exact material when establishing procedures for accidental exposure, spills, contamination control, environmental release, waste collection, and disposal.

The material should be secured against unauthorized access and kept away from children, pets, food, beverages, and non-research environments.

Packaging, Labeling & Storage

The supplied information describes professional moisture-resistant and UV-protective packaging. No packaging specification, validation study, or supporting documentation was supplied to independently confirm those performance characteristics.

The source recommends storing the material between 15°C and 25°C in a dry, airtight container protected from light. These are retained as supplied storage conditions rather than presented as independently validated Raw Lab Chems stability specifications.

Researchers should follow batch-specific documentation, applicable SDS information, and institutional chemical-storage requirements. Laboratory containers should remain appropriately labeled to preserve compound identity and minimize the possibility of material mix-ups.

Storage history should be recorded when temperature, moisture, light exposure, or other environmental variables could affect analytical observations or experimental reproducibility.

Intended Research Use & Market Positioning

GW-0742 is relevant to laboratory investigation of PPARβ/δ signaling, receptor-mediated transcription, ligand-receptor interactions, comparative PPAR chemistry, analytical method development, and structural investigation of related halogenated ligands.

The supplied material also discusses experimental research concerning glucose utilization, lipid oxidation, mitochondrial biology, cholesterol transport, cardiac models, and skeletal-muscle models. These topics describe research areas and should not be interpreted as claims that the product improves metabolism, cardiovascular function, physical performance, body composition, or health.

Researchers comparing related catalog materials can separately examine Raw Lab Chems GW-0742 Capsules and SR-9009 Powder (Stenabolic). These are distinct research materials or formulations and should not be considered chemically or analytically interchangeable.

The Raw Lab Chems GW-0742 Powder research listing provides the catalog reference for the material described here.

No medical, therapeutic, diagnostic, veterinary, weight-management, metabolic-enhancement, bodybuilding, athletic-performance, or consumptive application is represented by this description.

Ordering, Availability & Fulfillment

Institutional procurement of GW-0742 should begin with confirmation of the required chemical identity, analytical documentation, institutional authorization, and any jurisdiction-specific requirements applicable to the proposed research.

The supplied material describes moisture-resistant packaging and worldwide shipping. These statements are not presented as verified Raw Lab Chems fulfillment guarantees because supporting logistics and packaging documentation were not supplied.

No claims are made concerning current inventory, package sizes, dispatch schedules, delivery times, shipping destinations, courier services, tracking, payment methods, customs processing, or geographic availability.

Researchers and institutions remain responsible for determining whether acquisition, possession, import, export, transfer, storage, and investigation of GW-0742 are permitted and appropriately authorized under applicable requirements.

Legal & Regulatory Disclaimer

For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.

GW-0742 is presented as an experimental laboratory research compound. Regulatory treatment may differ according to jurisdiction, intended activity, institutional requirements, and applicable chemical, research, medicines, or sporting frameworks.

Researchers and institutions are responsible for determining and complying with requirements governing acquisition, possession, licensing, import, export, transfer, storage, security, laboratory investigation, environmental handling, and disposal.

A research-use designation does not establish universal legality, medical approval, suitability as a dietary supplement, or exemption from medicines, anti-doping, chemical-control, institutional, or other applicable requirements.

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “GW-0742 Powder”
Shipping & Delivery